Reduced gamma-aminobutyric acid concentration is associated with physical disability in progressive multiple sclerosis

Abstract

Neurodegeneration is thought to be the major cause of ongoing, irreversible disability in progressive stages of multiple sclerosis. Gamma-aminobutyric acid is the principle inhibitory neurotransmitter in the brain. The aims of this study were to investigate if gamma-aminobutyric acid levels (i) are abnormal in patients with secondary progressive multiple sclerosis compared with healthy controls; and (ii) correlate with physical and cognitive performance in this patient population. Thirty patients with secondary progressive multiple sclerosis and 17 healthy control subjects underwent single-voxel MEGA-PRESS (MEscher-GArwood Point RESolved Spectroscopy) magnetic resonance spectroscopy at 3 T, to quantify gamma-aminobutyric acid levels in the prefrontal cortex, right hippocampus and left sensorimotor cortex. All subjects were assessed clinically and underwent a cognitive assessment. Multiple linear regression models were used to compare differences in gamma-aminobutyric acid concentrations between patients and controls adjusting for age, gender and tissue fractions within each spectroscopic voxel. Regression was used to examine the relationships between the cognitive function and physical disability scores specific for these regions with gamma-aminobuytric acid levels, adjusting for age, gender, and total N-acetyl-aspartate and glutamine-glutamate complex levels. When compared with controls, patients performed significantly worse on all motor and sensory tests, and were cognitively impaired in processing speed and verbal memory. Patients had significantly lower gamma-aminobutyric acid levels in the hippocampus (adjusted difference = -0.403 mM, 95% confidence intervals -0.792, -0.014, P = 0.043) and sensorimotor cortex (adjusted difference = -0.385 mM, 95% confidence intervals -0.667, -0.104, P = 0.009) compared with controls. In patients, reduced motor function in the right upper and lower limb was associated with lower gamma-aminobutyric acid concentration in the sensorimotor cortex. Specifically for each unit decrease in gamma-aminobutyric acid levels (in mM), there was a predicted -10.86 (95% confidence intervals -16.786 to -4.482) decrease in grip strength (kg force) (P < 0.001) and -8.74 (95% confidence intervals -13.943 to -3.015) decrease in muscle strength (P < 0.006). This study suggests that reduced gamma-aminobutyric acid levels reflect pathological abnormalities that may play a role in determining physical disability. These abnormalities may include decreases in the pre- and postsynaptic components of gamma-aminobutyric acid neurotransmission and in the density of inhibitory neurons. Additionally, the reduced gamma-aminobutyric acid concentration may contribute to the neurodegenerative process, resulting in increased firing of axons, with consequent increased energy demands, which may lead to neuroaxonal degeneration and loss of the compensatory mechanisms that maintain motor function. This study supports the idea that modulation of gamma-aminobutyric acid neurotransmission may be an important target for...

Altered hippocampal GABA and glutamate levels and uncoupling from functional connectivity in multiple sclerosis

“…Previous functional MRI study also revealed similar patterns of FC abnormalities for the left and right hippocampi (Rocca et al, ). Moreover, the reduced GABA concentration in the right hippocampus had been reported in patients with progressive MS (Cawley et al, ). Therefore, although the current study only investigated the MRS and FC changes for the left hippocampus, the symmetric findings are to be expected for the contralateral one.…”

“…Several pioneering MRS studies have revealed significantly lower GABA+ levels in the hippocampus of patients with secondary progressive MS (Cawley et al, ), and lower Glu levels in the sensorimotor and parietal regions in patients with RRMS (Nantes et al, ). This study is the first to show that patients with RRMS exhibit both lower GABA+ and Glu levels in the hippocampus, which may reflect dysfunctional glutamatergic and GABAergic systems.…”

Chronic demyelination-induced seizures

“…Magnetic resonance imaging (MRI) of MS+S patients demonstrates abundant temporal leukocortical lesions, and hippocampal accumulation of demyelinating foci (Kutzelnigg et al, 2005; Martinez-Lapiscina et al, 2013; Cawley et al, 2015; Calabrese et al, 2016) in addition to findings common to MS, such as global cortical thinning and ventricular hypertrophy (Zivadinov et al, 2016). …”

GABA quantitation using MEGA-PRESS: Regional and hemispheric differences

“…5 Studies are ongoing to assess the potential of brain GABA levels as a neurochemical biomarker for various neurological and psychiatric disorders. 6,7 Consequently, reliable and accurate estimation of GABA levels in key brain regions of healthy individuals has clinical value.…”